Back
Viatris Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Sell
36
VTRS
Viatris
Last Price:
13.3800
Seasonality Move:
5.12%
Sell
24
LXRX
Lexicon Pharmaceuticals
Last Price:
0.87
Seasonality Move:
18.61%
Sell
36
Viatris (VTRS)
is a Sell
Is Viatris a Buy, Sell or Hold?
- The current Viatris [VTRS] share price is $13.3700. The Score for VTRS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- VTRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $0.86. The Score for LXRX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTRS Stock Price Chart
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $0.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VTRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 69.22 | Buy |
| Chaikin Money Flow: | 2599041 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.567 - 13.027) | Buy |
| Bollinger Bands (100): | (11.1966 - 12.3166) | Buy |
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 28.27 | Sell |
| Chaikin Money Flow: | 6632719 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.95 - 1.81) | Sell |
| Bollinger Bands (100): | (1.34 - 2.02) | Sell |
VTRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.03 | Buy |
| 20-day SMA: | 12.49 | Buy |
| 50-day SMA: | 11.93 | Buy |
| 200-day SMA: | 11.61 | Buy |
| 8-day EMA: | 13.05 | Buy |
| 20-day EMA: | 12.63 | Buy |
| 50-day EMA: | 12.13 | Buy |
| 200-day EMA: | 11.51 | Buy |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.92 | Sell |
| 20-day SMA: | 1.25 | Sell |
| 50-day SMA: | 1.52 | Sell |
| 200-day SMA: | 1.86 | Sell |
| 8-day EMA: | 0.93 | Sell |
| 20-day EMA: | 1.17 | Sell |
| 50-day EMA: | 1.43 | Sell |
| 200-day EMA: | 1.7 | Sell |
Viatris Earnings Growth & VTRS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.27 per share, and a decrease next year of $0.02 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.19 per share.
Viatris Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexicon Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||